In breast cancers, PI3K/Akt/mTOR is the most frequently activated signaling pathway [64], with more than 70% of breast cancers presenting molecular alterations in one or more components of the PI3K/Akt pathway [65]. The gene discussed is MTOR; the disease is breast carcinoma.